Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$8.07 USD
+0.40 (5.22%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $8.06 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.49 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
2.27% |
---|---|
Current Year | -1.75 |
Next Year | -1.93 |
EPS (TTM) | -1.96 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.43 | -1.75 | -1.93 |
# of Estimates | 5 | 5 | 6 | 4 |
Most Recent Consensus | -0.46 | -0.43 | -1.78 | -2.01 |
High Estimate | -0.43 | -0.42 | -1.66 | -1.54 |
Low Estimate | -0.46 | -0.45 | -1.83 | -2.26 |
Year ago EPS | -0.53 | -0.50 | -1.96 | -1.75 |
Year over Year Growth Est. | 16.98% | 14.00% | 10.71% | -9.90% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 5 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.43 | -1.75 | -1.93 |
7 Days Ago | -0.44 | -0.43 | -1.75 | -1.93 |
30 Days Ago | -0.44 | -0.43 | -1.75 | -1.93 |
60 Days Ago | -0.50 | -0.15 | -1.96 | -1.93 |
90 Days Ago | -0.50 | -0.15 | -2.02 | -1.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.43 | -1.73 | -1.54 |
Zacks Consensus Estimate | -0.44 | -0.43 | -1.75 | -1.93 |
Earnings ESP | 2.27% | 0.46% | 1.24% | 20.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.49 | -0.44 | -0.50 | -0.53 | NA |
Estimate | -0.49 | -0.46 | -0.58 | -0.54 | NA |
Difference | 0.00 | 0.02 | 0.08 | 0.01 | 0.03 |
Surprise | 0.00% | 4.35% | 13.79% | 1.85% | 5.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more